USP22 and exocrine pancreatic carcinoma: Collectively, these findings validated the hypothesis that CTBP1-AS2 could function as a ceRNA to facilitate pancreatic carcinoma cell proliferation, migration and invasion by adsorbing miR-141-3p and upregulating USP22 expression.